| Alan Samuel Slipak, | |
|
320 E North Ave, Pittsburgh, PA 15212-4756 | |
| (412) 359-3166 | |
| Not Available |
| Full Name | Alan Samuel Slipak |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 10 Years |
| Location | 320 E North Ave, Pittsburgh, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053739532 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD470719 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Allegheny General Hospital | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vantage Physical Therapy And Rehabilitation Inc | 3072424886 | 168 |
| Allegheny Clinic | 5395649586 | 1941 |
| Keystone Rehabilitation Systems Inc | 7012826753 | 505 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 2, a Phase IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non Responders (INR) after at least 12 months of highly active anti-retroviral therapy (HAART).
GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. David J. Kappos and the United States Patent and Trademark Office).
Surgery patients are much less likely to get a blood clot in the lower extremities or lungs if they receive preventive treatment based on their individual clotting risk, in addition to walking soon after the operation.
The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) will announce the results of a survey conducted with Dermik Laboratories, a business of sanofi-aventis U.S. LLC, which found that 53 percent of women who are considering facial plastic surgery say the economy has affected their decision to move forward with anti-aging procedures or treatment options. As a result, slightly more than 30 percent of women considering facial plastic surgery in the near future have looked for less costly procedures or treatment alternatives. The survey will be presented today at the Academy's Annual Fall meeting and will be available on a live Web cast at www.aafprs.org.
› Verified 8 days ago
| Entity Name | Allegheny Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073081493 PECOS PAC ID: 5395649586 Enrollment ID: O20040310000602 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 2, a Phase IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non Responders (INR) after at least 12 months of highly active anti-retroviral therapy (HAART).
GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. David J. Kappos and the United States Patent and Trademark Office).
Surgery patients are much less likely to get a blood clot in the lower extremities or lungs if they receive preventive treatment based on their individual clotting risk, in addition to walking soon after the operation.
The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) will announce the results of a survey conducted with Dermik Laboratories, a business of sanofi-aventis U.S. LLC, which found that 53 percent of women who are considering facial plastic surgery say the economy has affected their decision to move forward with anti-aging procedures or treatment options. As a result, slightly more than 30 percent of women considering facial plastic surgery in the near future have looked for less costly procedures or treatment alternatives. The survey will be presented today at the Academy's Annual Fall meeting and will be available on a live Web cast at www.aafprs.org.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alan Samuel Slipak, 1307 Federal St, Pittsburgh, PA 15212-4769 Ph: (877) 660-6777 | Alan Samuel Slipak, 320 E North Ave, Pittsburgh, PA 15212-4756 Ph: (412) 359-3166 |
News Archive
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 2, a Phase IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non Responders (INR) after at least 12 months of highly active anti-retroviral therapy (HAART).
GlaxoSmithKline (NYSE: GSK) today announced that it has reached agreement with the United States Patent and Trademark Office (USPTO) to join the USPTO's motion to dismiss its litigation over Final Regulations published in August 2007 (Triantafyllos Tafas and SmithKline Beecham Corporation, SmithKline Beecham PLC and Glaxo Group Limited vs. David J. Kappos and the United States Patent and Trademark Office).
Surgery patients are much less likely to get a blood clot in the lower extremities or lungs if they receive preventive treatment based on their individual clotting risk, in addition to walking soon after the operation.
The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) will announce the results of a survey conducted with Dermik Laboratories, a business of sanofi-aventis U.S. LLC, which found that 53 percent of women who are considering facial plastic surgery say the economy has affected their decision to move forward with anti-aging procedures or treatment options. As a result, slightly more than 30 percent of women considering facial plastic surgery in the near future have looked for less costly procedures or treatment alternatives. The survey will be presented today at the Academy's Annual Fall meeting and will be available on a live Web cast at www.aafprs.org.
› Verified 8 days ago
Dr. Timothy Joseph Sauber Ii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1307 Federal St Ste 2, Pittsburgh, PA 15212 Phone: 877-660-6777 Fax: 412-359-8055 | |
Dr. Nicholas George Sotereanos, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1307 Federal St Ste 2, Pittsburgh, PA 15212 Phone: 877-660-6777 Fax: 412-359-8055 | |
William Hogan, Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 320 E North Ave, Pittsburgh, PA 15212 Phone: 412-708-1511 | |
Dr. Robert G Liss, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5820 Centre Ave, Pittsburgh, PA 15206 Phone: 412-661-5500 Fax: 412-661-4365 | |
David Phillips, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1307 Federal St Ste 2, Pittsburgh, PA 15212 Phone: 877-660-6777 Fax: 412-359-8055 | |
Tara Degnan, PA-C Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Delafield Rd Ste 1040, Pittsburgh, PA 15215 Phone: 412-782-3990 | |
Mark Petrocelli, D.O. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 9104 Babcock Blvd Fl 5, Pittsburgh, PA 15237 Phone: 412-748-7444 |